68 / 89
68
microscopy in 112 patients. Angiology
1992;43(3 Pt 1):203-10.
20.
Riboldi P, Asero R, Origgi L, Crespi S, Meroni
PL, Sguotti C, Sabbadini MG. Antinuclear
antibodies in progressive systemic sclerosis.
Clin Exp Rheumatol 1985;3:205-11.
21.
Kipnis RJ, Craft J, Hardin JA. The analysis of
antinuclear and antinucleolar autoantibodies of
scleroderma
by
radioimmunoprecipitation
assays. Arthritis Rheum 1990;33:1431-7.
22.
Simeón-Aznar CP, Fonollosa-Plá V, Tolosa-
Vilella C, Espinosa-Garriga G, Ramos-Casals M,
Campillo-Grau M, et al: Registry of the Spanish
Network for Systemic Sclerosis: Clinical pattern
according
to
cutaneous
subsets
and
immunological status. Semin Arthritis Rheum
2012;41:789-800.
23.
Hunzelmann N, Genth E, Krieg T, Lehmacher
W, Melchers I, Meurer M, et al. Registry of the
German Network for Systemic Scleroderma.
The registry of the German Network for
Systemic Scleroderma: frequency of disease
subsets and patterns of organ involvement.
Rheumatology (Oxford) 2008;47:1185-92.
24.
Aeschlimann A, Meyer O, Bourgeois P, Haim T,
Belmatoug N, Palazzo E, Kahn MF. Anti-Scl-70
antibodies detected by immunoblotting in
progressive systemic sclerosis: specificity and
clinical
correlations.
Ann
Rheum
Dis
1989;48:992-7.